T. P. Brady et al. / Bioorg. Med. Chem. Lett. 14 (2004) 5035–5039
5039
K. J. M.; Cole, N.; Moreira, J. E.; Terasaki, M.; Siggia, E.;
Lippincott-Schwartz, J. J. Cell Biol. 1997, 139, 1137–1155.
9. Takizawa, P. A.; Yucel, J. K.; Veit, B.; Faulkner, J. D.;
Deernick, T.; Soto, G.; Ellisman, M.; Malhotra, V. Cell
1993, 73, 1079–1090; Veit, B.; Yucel, J. K.; Malhotra, V. J.
Cell Biol. 1993, 122, 1197–1206.
10. Radeke, H. S.; Digits, C. A.; Casaubon, R. L.; Snapper,
M . L.Chem. Biol. 1999, 6, 639–647; Radeke, H. S.;
Snapper, M. L. Bioorg. Med. Chem. 1998, 6, 1227–1232;
Casaubon, R.; Snapper, M. L. Bioorg. Med. Chem. Lett.
2001, 11, 133–136; Jamora, C.; Takizawa, P. A.; Zaarour,
R. F.; Denesvre, C.; Faulkner, D. J.; Malhotra, V. Cell
1999, 91, 617–626.
(c 0.3, CH2Cl2); 1H NMR (400MHz, CDCl3) d 6.24 (d,
J = 5.6Hz, 1H), 5.42 (s, 1H), 4.87 (s, 1H), 4.48 (d,
J = 10.8Hz, 1H), 3.25 (m, 1H), 3.07 (t, J = 10.4Hz,
1H), 2.68 (dd, J = 3.2, 18.8Hz, 1H), 2.52 (dd, J = 10.8,
19.2Hz, 1H), 2.23 (s, 3H), 1.03 (s, 9H); 13C NM R
(100MHz, CDCl3) d 204.2, 174.5, 151.2, 113.1, 107.7,
85.1, 45.6, 42.8, 36.6, 30.3, 28.8, 27.2, 19.9, 14.1; HRMS
calcd for C14H20O4 (M+Na+) 275.1260, found 275.1281.
25
Compound 10: Rf = 0.4 (50% ether in hexanes); ½aꢁD
+9.18, (c 0.43, CH2Cl2); 1H NMR (400MHz, CDCl3) d
6.44 (d, J = 5.2Hz, 1H), 5.65 (d, J = 6Hz, 1H), 4.84 (s,
1H), 4.57 (s, 1H), 2.75 (m, 1H), 2.22 (m, 1H), 2.13 (dd,
J = 5.2, 18Hz, 1H), 1.65 (dd, J = 10.8, 18.8Hz, 1H), 1.54
(s, 3H), 0.69 (s, 9H); 13C NMR (100MHz, CDCl3) d 173.7,
168.6, 151.5, 136.1, 112.1, 106.8, 102.1, 47.3, 40.8, 36.3,
30.1, 28.4, 27.0, 20.3; HRMS calcd for C14H20O5
(M+Na+) 291.1209, found 291.1228.
11. Hochlowski, J. E.; Faulkner, D. J.; Matsumoto, J.;
Clardy, J. J. Org. Chem. 1983, 48, 1141–1142.
12. Brady, T. P.; Kim, S. H.; Wen, K.; Theodorakis, E. A.
Angew. Chem., Int. Ed. 2004, 43, 739–742.
13. Compound 16 is readily available from D-mannitol using
the procedures reported in the following publications:
Schmid, C. R.; Bryant, J. D.; Dowlatzedah, M.; Phillips, J.
L.; Prather, D. E.; Shantz, R. D.; Sear, N. L.; Vianco, C.
S. J. Org. Chem. 1991, 56, 4056–4058; Mann, J.; Wey-
mouth-Wilson, A. Carbohydr. Res. 1991, 216, 511–515;
Fazio, F.; Scheider, M. P. Tetrahedron: Asymmetry 2000,
11, 1869–1876.
14. Sahlberg, C. Tetrahedron Lett. 1992, 33, 679–682.
15. Takai, K.; Tagashira, M.; Kuroda, T.; Oshima, K.;
Utimoto, K.; Nozaki, H. J. Am. Chem. Soc. 1986, 108,
6048–6050.
16. All new compounds exhibited satisfactory spectroscopic
and analytical data. Yields refer to spectroscopically and
chromatographically homogeneous materials.
17. (a) For selected reports on the Baeyer–Villiger reaction
see: Hudlicky, M. In Oxidations in Organic Chemistry;
Am. Chem. Soc.: Washington, DC, 1990; pp 186–195;
Mislow, K.; Brenner, J. J. Am. Chem. Soc. 1953, 75,
2318–2322; Goodman, R. M.; Kishi, Y. J. Am. Chem. Soc.
1998, 120, 9392–9393.
20. Similar results were obtained with experiments in HeLa
cells.
21. Reagents and cells: NRK cells were plated on 12mm glass
coverslips coated with Pronectin F (Sigma) and grown in
complete medium (250lL per coverslip), consisting of
alpha MEM medium (GIBCO) with 10% fetal calf serum,
2mM L-glutamine and 25mMHepes pH7.4, at 37 ꢁC in a
5% CO2 cell incubator. Stock solution (5mg/mL) of
norrisolide and analogues were made in DMSO and
stored at ꢀ20ꢁC. The working concentration of the
compounds was 30lMfor each coverslip. To half of the
coverslips (70% confluent) were added norrisolide or
analogues (2.5lL of the stock solutions). To the other
half were added 2.5lL of DMSO as negative control. Both
groups of cells were incubated at 37ꢁC for 60min. Part of
the treated cells (Fig. 1, column 2) and part of the control
cells (Fig. 1, column 1) were then fixed with 4% formal-
dehyde and processed for immunofluorescence micro-
scopy. The remaining cells were washed four times with
phosphate-buffered saline (PBS) (150mMNaCl, 1.8mM
NaH2PO4, 8.4mMNa 2HPO4). The cells were incubated in
fresh complete medium at 37ꢁC for 90min, then fixed with
4% formaldehyde and processed for immunofluorescence
microscopy (Fig. 3, column 3). Immunofluorescence
microscopy: For fluorescent labeling, cells were incubated
in blocking buffer (PBS containing 2.5% fetal bovine
serum and 0.1% Tween 20) for 30min at room tempera-
ture. The cells were then incubated for 1h at room
temperature in primary antibody diluted in blocking
buffer. Rat tubulin antibody (1:75) (Accurate Chemicals)
was used to detect microtubules; rabbit Mannosidase II
antibody (1:2000) (a gift from Dr. Kelly Moreman,
Vanderbilt University, TN) was used to visualize Golgi
apparatus. The cells were then washed three times with
PBS and incubated with secondary antibody, diluted in
blocking buffer, for 1h at room temperature. Alexa fluor
488 goat anti mouse (1:500) and Alexa Fluor 594 goat anti
rabbit (1:500) from Molecular Probes were used. Cells
were washed three times with PBS containing Hoescht
(1:100,000) (H33342, Molecular Probes) to stain DNA.
Coverslips were then mounted onto glass slides and
visualized using a Nikon micophot-FXA fluorescence
microscope at 60· magnification.
18. Spectroscopic and analytical data for compounds 7–8.
25
Compound 7: Rf = 0.4 (50% ether in hexanes); ½aꢁD +1.67,
(c 0.3, CH2Cl2); IR (film) mmax 2924, 1802, 1765, 1646,
1458, 1370, 1260, 1213, 1142, 1014, 704cmꢀ1 1H NM R
;
(400MHz, C6D6) d 6.45 (d, J = 1.2Hz, 1H), 4.82 (s, 1H),
4.68 (s, 1H), 2.68 (d, J = 8Hz, 1H), 2.41 (dd, J = 8.4,
17.6Hz, 1H), 2.11 (dd, J = 2.8, 17.6Hz, 1H), 1.90 (t,
J = 10.4Hz, 1H), 1.48 (s, 3H), 1.39–0.77 (m, 11H), 0.80 (s,
3H), 0.79 (s, 3H), 0.43 (s, 3H); 13C NMR (100MHz, C6D6)
d 174.1, 168.2, 146.7, 112.3, 99.1, 58.3, 58.0, 46.3, 43.7,
41.6, 39.6, 33.3, 33.2, 32.6, 30.2, 26.7, 25.1, 20.7, 20.3, 14.1;
HRMS calcd for C20H30O4 (M+Na+) 357.2042, found
357.2019. Compound 8: Rf = 0.6 (50% ether in hexanes);
25
½aꢁD +2.9, (c 0.7, CH2Cl2); IR (film) mmax 2945, 2855, 1791,
; R
1723, 1459, 1362, 1147, 1063, 899cmꢀ1 1H NM
(400MHz, CDCl3) d 5.13 (s, 1H), 5.05 (s, 1H), 4.56 (d,
J = 4.4Hz, 1H), 3.07 (m, J = 4.4Hz, 1H), 2.68 (dd, J = 9.2,
18Hz, 1H), 2.52 (dd, J = 5.2, 18Hz, 1H), 2.28 (s, 3H), 2.07
(t, J = 8Hz, 1H), 1.72–0.85 (m, 11H), 0.85 (s, 6H), 0.64 (s,
3H); 13C NMR (100MHz, CDCl3) d 204.8, 175.3, 148.5,
112.0, 88.0, 58.5, 58.1, 43.6, 43.2, 41.4, 41.3, 39.6, 34.2,
33.2, 33.1, 26.7, 25.3, 20.5, 19.9, 14.1; HRMS calcd for
C20H30O3 (M+H+) 319.2273, found 319.2298.
22. The fragmentation of the Golgi membranes is evidenced
by the appearance of Golgi vesicles (shown as red spots) in
the cytoplasm.
19. Spectroscopic and analytical data for compounds 9–10.
25
Compound 9: Rf = 0.5 (60% ether in hexanes). ½aꢁD +13.7,